Search Ontology:
ChEBI
(R)-lisofylline
- Term ID
- CHEBI:143527
- Synonyms
-
- (-)-lisofylline
- (R)-1-(5-hydroxyhexyl)-3,7-dimethylxanthine
- (R)-LSF
- 1-(5R-hydroxyhexyl)-3,7-dimethylxanthine
- 1-[(5R)-5-hydroxyhexyl]-3,7-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
- 1-[(5R)-5-hydroxyhexyl]-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione
- 1-[(R)-5-hydroxyhexyl]theobromine
- CT 1501R
- CT-1501R
- lisofilina
- lisofylline
- lisofyllinum
- lisophylline
- ProTec
- Definition
- A 1-(5-hydroxyhexyl)-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione that has (R)-configuration. A synthetic small molecule which was under development for the treatment of type 1 diabetes mellitus.
- References
-
- cas:100324-81-0
- drugbank:DB12406
- kegg.drug:D04748
- patent:WO2009099582
- pubmed:10330034
- pubmed:11902249
- pubmed:12242464
- pubmed:12717280
- pubmed:15588708
- pubmed:25663650
- pubmed:28730281
- pubmed:30300750
- pubmed:7735959
- wikipedia.en:Lisofylline
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from (R)-lisofylline
Phenotype where environments contain (R)-lisofylline
Phenotype modified by environments containing (R)-lisofylline
Phenotype affecting (R)-lisofylline
Human Disease Model